New study shows targeted therapy needed for breast cancer with brain metastases

December 07, 2016

PITTSBURGH, Dec. 7, 2016 - Researchers at the University of Pittsburgh Cancer Institute (UPCI) and Magee-Womens Research Institute (MWRI) have discovered molecular changes in the primary tumor of breast cancer patients who developed brain metastases. The finding is expected to lead to improved diagnosis and targeted therapies.

The results, to be published in the Journal of the American Medical Association (JAMA) Oncology and presented this week at the 2016 San Antonio Breast Cancer Symposium, indicate that patients' treatments should be tailored not only for the original breast cancer, but also the brain tumors, said Adrian Lee, Ph.D., director of the Institute for Precision Medicine, a joint effort by UPMC and the University of Pittsburgh, and director of the Women's Cancer Research Center, a collaboration between UPCI and MWRI.

"The brain is a common and catastrophic site of metastasis for breast cancer patients," said Lee. "Our study showed that despite the large degree of similarity between the initial breast tumor and the brain metastatic tumor, there were enough alterations to support comprehensive profiling of metastases to potentially alter the course of treatment."

There are many types of breast cancers, and about 20 percent of them are identified as HER2-positive, meaning the cancer cells have more of a protein called HER2 that causes the cells to grow faster than those with normal levels of the protein. These patients' cancers typically respond to targeted therapies. However, breast cancer patients with brain metastases who are identified as HER2-negative do not respond favorably to the same therapies.

Lee's research team set out to determine if there were molecular differences in the primary breast tumors and their patient-matched brain metastatic tumors that would enhance treatment options.

Little research is available because there are few opportunities to study primary breast tissue with their patient-matched brain metastases. The research team tested tumors from 20 patients from two academic institutions, the University of Pittsburgh and the Royal College of Surgeons in Ireland. Among the discoveries was that the primary tumor initially identified as HER2-negative actually switched to HER2-positive in the metastatic brain tumor.

"This now means we can screen for presence of HER2 so that we can change and target the therapy to improve outcomes for our patients," said Dr. Lee.
-end-
Additional authors on this study are Nolan Priedigkeit, B.S., Yijing Chen, B.S., Ahmed Basudan, B.S., Rebecca J. Watters, Ph.D., Roby Thomas, M.D., Peter C. Lucas, M.D., Ph.D., Rohit Bhargava, M.D., Ronald L. Hamilton, M.D., Shannon L. Puhalla, M.D., Nancy E. Davidson, M.D., Steffi Oesterreich, Ph.D., and Adam M. Brufsky, M.D., Ph.D., all of UPCI; Ryan J. Hartmaier, Ph.D., and Juliann Chmielecki, Ph.D., both of the Foundation Medicine, Cambridge, Massachusetts; Damir Vareslija, Ph.D., and Leonie Young, Ph.D., both of the Royal College of Surgeons in Ireland; and Jose P. Leone, M.D., of the University of Iowa.

This research was supported by the Breast Cancer Research Foundation, National Cancer Institute grant P30CA047904, Fashion Footwear Association of New York, the Shear Family Foundation, Magee-Womens Research Institute and Foundation, Susan G. Komen for the Cure, National Institute of General Medical Sciences grants 2T32GM008424-21 and 5F30CA203095, and the Irish Cancer Society Collaborative Cancer Research Centre grant CCRC13GAL.

Several of the authors disclosed conflicts of interest, which can be viewed on the JAMA Oncology publication.

About UPCI

As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. Investigators at UPCI, a partner with UPMC CancerCenter, are world-renowned for their work in clinical and basic cancer research.

http://www.upmc.com/media

University of Pittsburgh Schools of the Health Sciences

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.